Literature DB >> 12431838

Estrogen action and cytoplasmic signaling pathways. Part II: the role of growth factors and phosphorylation in estrogen signaling.

Paul H Driggers1, James H Segars.   

Abstract

In recent years, distinct signaling pathways involving specific complexes of cytoplasmic proteins have been shown to orchestrate estrogen action. These pathways might supplement or augment genomic effects of estrogen that are attributable to transcriptional activation by liganded receptor. Signals might be transduced through phosphorylation of the estrogen receptors (ERs), or indirectly through effects upon transcriptional coactivators or cell receptors. Estrogen signaling is coupled to growth factor signaling with feedback mechanisms directly impacting function of growth factor receptors. These signaling pathways regulate important physiological processes, such as cell growth and apoptosis. Here, we focus on cytoplasmic signaling pathways leading to activation of ERs.

Mesh:

Substances:

Year:  2002        PMID: 12431838      PMCID: PMC4152897          DOI: 10.1016/s1043-2760(02)00634-3

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  63 in total

1.  Phosphorylation of steroid receptor coactivator-1. Identification of the phosphorylation sites and phosphorylation through the mitogen-activated protein kinase pathway.

Authors:  B G Rowan; N L Weigel; B W O'Malley
Journal:  J Biol Chem       Date:  2000-02-11       Impact factor: 5.157

2.  Activation of the p38 mitogen-activated protein kinase pathway by estrogen or by 4-hydroxytamoxifen is coupled to estrogen receptor-induced apoptosis.

Authors:  C C Zhang; D J Shapiro
Journal:  J Biol Chem       Date:  2000-01-07       Impact factor: 5.157

3.  Protein kinase C alpha expression is inversely related to ER status in endometrial carcinoma: possible role in AP-1-mediated proliferation of ER-negative endometrial cancer.

Authors:  D B Fournier; M Chisamore; J R Lurain; A W Rademaker; V C Jordan; D A Tonetti
Journal:  Gynecol Oncol       Date:  2001-06       Impact factor: 5.482

4.  Inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase activity in MCF-7 cells prevents estrogen-induced mitogenesis.

Authors:  E K Lobenhofer; G Huper; J D Iglehart; J R Marks
Journal:  Cell Growth Differ       Date:  2000-02

5.  The proto-oncoprotein Brx activates estrogen receptor beta by a p38 mitogen-activated protein kinase pathway.

Authors:  P H Driggers; J H Segars; D M Rubino
Journal:  J Biol Chem       Date:  2001-09-28       Impact factor: 5.157

6.  Estradiol-induced IP(3) mediates the estrogen receptor activity expressed in human cells.

Authors:  M Marino; E Distefano; A Trentalance; C L Smith
Journal:  Mol Cell Endocrinol       Date:  2001-08-20       Impact factor: 4.102

7.  Interaction between estradiol and cAMP in the regulation of specific gene expression.

Authors:  M K el-Tanani; C D Green
Journal:  Mol Cell Endocrinol       Date:  1996-11-29       Impact factor: 4.102

8.  Estrogen receptor activation function 1 works by binding p160 coactivator proteins.

Authors:  P Webb; P Nguyen; J Shinsako; C Anderson; W Feng; M P Nguyen; D Chen; S M Huang; S Subramanian; E McKinerney; B S Katzenellenbogen; M R Stallcup; P J Kushner
Journal:  Mol Endocrinol       Date:  1998-10

9.  Alteration in the agonist/antagonist balance of antiestrogens by activation of protein kinase A signaling pathways in breast cancer cells: antiestrogen selectivity and promoter dependence.

Authors:  N Fujimoto; B S Katzenellenbogen
Journal:  Mol Endocrinol       Date:  1994-03

10.  Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase.

Authors:  S Kato; H Endoh; Y Masuhiro; T Kitamoto; S Uchiyama; H Sasaki; S Masushige; Y Gotoh; E Nishida; H Kawashima; D Metzger; P Chambon
Journal:  Science       Date:  1995-12-01       Impact factor: 47.728

View more
  64 in total

1.  Suppression subtractive hybridization and microarray identification of estrogen-regulated hypothalamic genes.

Authors:  Anna Malyala; Patrick Pattee; Srinivasa R Nagalla; Martin J Kelly; Oline K Rønnekleiv
Journal:  Neurochem Res       Date:  2004-06       Impact factor: 3.996

2.  Opposite regulation of estrogen receptor-α and its variant ER-α36 by the Wilms' tumor suppressor WT1.

Authors:  Lianguo Kang; Lei Wang; Zhao-Yi Wang
Journal:  Oncol Lett       Date:  2011-01-21       Impact factor: 2.967

3.  A variant of estrogen receptor-{alpha}, hER-{alpha}36: transduction of estrogen- and antiestrogen-dependent membrane-initiated mitogenic signaling.

Authors:  Zhaoyi Wang; Xintian Zhang; Peng Shen; Brian W Loggie; Yunchao Chang; Thomas F Deuel
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-05       Impact factor: 11.205

4.  Computational method for discovery of estrogen responsive genes.

Authors:  Suisheng Tang; Sin Lam Tan; Suresh Kumar Ramadoss; Arun Prashanth Kumar; Man-Hung Eric Tang; Vladimir B Bajic
Journal:  Nucleic Acids Res       Date:  2004-12-01       Impact factor: 16.971

5.  Rapid effects of aromatase inhibition on male reproductive behaviors in Japanese quail.

Authors:  Charlotte A Cornil; Mélanie Taziaux; Michelle Baillien; Gregory F Ball; Jacques Balthazart
Journal:  Horm Behav       Date:  2005-06-16       Impact factor: 3.587

Review 6.  Multiple pathways transmit neuroprotective effects of gonadal steroids.

Authors:  Damani N Bryant; Laird C Sheldahl; Lisa K Marriott; Robert A Shapiro; Daniel M Dorsa
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

Review 7.  Functional significance of the rapid regulation of brain estrogen action: where do the estrogens come from?

Authors:  Charlotte A Cornil; Gregory F Ball; Jacques Balthazart
Journal:  Brain Res       Date:  2006-09-15       Impact factor: 3.252

8.  Human uterine smooth muscle and leiomyoma cells differ in their rapid 17beta-estradiol signaling: implications for proliferation.

Authors:  Erica N Nierth-Simpson; Melvenia M Martin; Tung-Chin Chiang; Lilia I Melnik; Lyndsay V Rhodes; Shannon E Muir; Matthew E Burow; John A McLachlan
Journal:  Endocrinology       Date:  2009-01-29       Impact factor: 4.736

9.  Estrogen Receptor β Mediated Neuroprotective Efficacy of Cicer microphyllum Seed Extract in Global Hypoxia.

Authors:  Deepti Sharma; Surya Narayan Biswal; Kushal Kumar; Pushpendar Bhardwaj; Kalpana Kumari Barhwal; Ashish Kumar; Sunil Kumar Hota; Om Prakash Chaurasia
Journal:  Neurochem Res       Date:  2017-08-31       Impact factor: 3.996

10.  Delayed and persistent ERK1/2 activation is required for 4-hydroxytamoxifen-induced cell death.

Authors:  Jian-Hua Zhou; David V Yu; Jingwei Cheng; David J Shapiro
Journal:  Steroids       Date:  2007-07-07       Impact factor: 2.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.